LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
23.69
-0.71 (-2.91%)
At close: Mar 5, 2026, 4:00 PM EST
23.55
-0.14 (-0.59%)
After-hours: Mar 5, 2026, 4:04 PM EST
LB Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for LB Pharmaceuticals stock have an average target of 49, with a low estimate of 34 and a high estimate of 78. The average target predicts an increase of 106.84% from the current stock price of 23.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 11, 2025.
Analyst Ratings
The average analyst rating for LB Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $27 → $35 | Strong Buy | Maintains | $27 → $35 | +47.74% | Dec 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $78 | Buy | Initiates | $78 | +229.25% | Oct 6, 2025 |
| Stifel | Stifel | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +13.97% | Oct 6, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $34 | Buy | Initiates | $34 | +43.52% | Oct 6, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.71
from -250.61
EPS Next Year
-4.14
from -3.71
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.21 | -3.47 | |
| Avg | -3.71 | -4.14 | |
| Low | -6.53 | -4.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.